✦ LIBER ✦

Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma

✍ Scribed by Aristides Polyzos; Konstantinos Syrigos; John Stergiou; Christos Panopoulos; Anna Potamianou; Lambros Vamvakas; Vassilios Georgoulias

Publisher: Springer
Year: 2005
Tongue: English
Weight: 185 KB
Volume: 55
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-004-0912-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I trial of weekly lomustine in p

A Phase I trial of weekly lomustine in patients with advanced cancer

✍ Charles A. Koller; Carolyn C. Gorski; Robert S. Benjamin; Sewa S. Legha; Nichola 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 2 views

Phase I trial of weekly docetaxel and ge

Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies

✍ Tarek Mekhail; Thomas E. Hutson; Paul Elson; G. Thomas Budd; Gordon Srkalovic; T 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## BACKGROUND A Phase I study using weekly docetaxel and gemcitabine was conducted to investigate toxicity; to determine the maximum tolerated dose (MTD) of each agent; and, in a preliminary fashion, to determine the antitumor activity of the combination. ## METHODS Docetaxel and gem

Phase II study of weekly docetaxel combi

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

✍ Toshiyuki Tsunoda; Tomonobu Koizumi; Muneharu Hayasaka; Kazuya Hirai; Shigeru Ko 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Phase I clinical trial of weekly combine

Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors

✍ Jacob Lokich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I and feasibility study of combined docetaxel (D) plus paclitaxel (P) was undertaken to determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) for each analogue delivered concomitantly on a weekly schedule. ## METHODS. Patients were accrued in 3-6 patient cohorts to P

Phase I dose-escalating study of 24-h co

Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer

✍ Biyun Wang; Wen Zhang; Xiaonan Hong; Ye Guo; Jin Li 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 261 KB

A phase II study of weekly docetaxel plu

A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma

✍ Ji-Youn Han; Dae Ho Lee; Hae Young Kim; Eun Kyung Hong; Sung Min Yoon; Jong Ho C 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND Docetaxel is an active agent in advanced nonsmall‐cell lung carcinoma (NSCLC) and demonstrates preclinical and clinical synergism with capecitabine. We conducted the current Phase II study to evaluate the efficacy and safety of the docetaxel/capecitabine combination in ch